000 04039nam a22005655i 4500
001 978-981-97-8410-3
003 DE-He213
005 20251030114918.0
007 cr nn 008mamaa
008 250102s2024 si | s |||| 0|eng d
020 _a9789819784103
_9978-981-97-8410-3
024 7 _a10.1007/978-981-97-8410-3
_2doi
050 4 _aRC1-1245
050 4 _aRC1-1245
072 7 _aMJ
_2bicssc
072 7 _aMJ
_2bicssc
072 7 _aMED045000
_2bisacsh
072 7 _aMJ
_2thema
072 7 _aMJ
_2thema
245 1 0 _aIrritable Bowel Syndrome
_h[electronic resource] /
_cedited by Takeshi Kamiya, Shin Fukudo.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aVIII, 208 p. 27 illus., 17 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aDefinition of irritable bowel syndrome -- The epidemiology of irritable bowel syndrome -- Part II. Pathophysiology -- Neurogastroenterology - Brain-Gut Axis, Stress and Psychological Factors -- Neuro-gastroenterology - Neurotransmitter, endocrine substance and motility -- Role of microbiota in the pathophysiology of irritable bowel syndrome -- Mucosal inflammation and visceral hypersensitivity in irritable bowel syndrome -- Genetic factors -- Part III. Diagnosis -- Diagnostic algorithm for IBS -- Differential diagnosis -- Comorbiditie -- Part IV. Treatment -- Pharmacotherapy for IBS-D -- Pharmacotherapy for irritable bowel syndrome with constipation -- GI motility modifier, bulking polymer and Herbal medicine -- Antidepressant, anxiolytics and psychotherapy -- Diet and behavioral modification for irritable bowel syndrome -- Probiotics and antibiotics -- Part V. Recent special topics -- Fecal Microbiota Transplantation for Treatment of Irritable Bowel Syndrome -- Clinical study design and evaluation of the efficacy in the treatment.
520 _aThis edited book brings together 5 general themes of irritable bowel syndrome (IBS), presenting the latest information on the epidemiology, pathophysiology, diagnosis, treatment and a number of current topics. IBS is a functional bowel disorder associated with chromic abdominal pain and altered bowel habits without identifiable organic etiology, however, to date there is no known, agreed-upon disease mechanism. This book offers insights into the various factors potentially contributing to the symptoms, and provides data on the various globally recognized strategies, including novel pharmacological treatment agents. It also discusses geographical differences and region-specific factors such as medical systems, life styles, dietary habits, gut microbiota, social stress, and genetics. The book promotes further exploration of the disease by offering a comprehensive bibliography for each chapter. It is a valuable and thought-provoking resource for clinicians, researchers, residents and PIs who are interested in the latest basic and clinical research on IBS.
650 0 _aInternal medicine.
650 0 _aMedicine, Psychosomatic.
_975198
650 1 4 _aInternal Medicine.
650 2 4 _aPsychosomatic Medicine.
_975200
650 2 4 _aInternal Medicine.
700 1 _aKamiya, Takeshi.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_990090
700 1 _aFukudo, Shin.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_990091
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819784097
776 0 8 _iPrinted edition:
_z9789819784110
776 0 8 _iPrinted edition:
_z9789819784127
856 4 0 _uhttps://doi.org/10.1007/978-981-97-8410-3
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c66306
_d66306